While tesamorelin raising GH and IGF-1 in people is well established, formal trials that pairs BPC with a GH peptide and tracks recovery outcomes has not been run yet
Over the past decade, senators Tom Carper (D-DE) and Bill Cassidy, MD, (R-LA) have repeatedly introduced bills that would do that
Phase 3 TRIUMPH trials use escalating subcutaneous doses: starting at 2mg weekly, titrating to 4mg, 8mg, and 12mg every 4 weeks
It exists in both reduced (GSH) and oxidized (GSSG) forms, forming a key regulatory system for redox balance
The new drug, however, will face competition soon enough, with other foreign pharmaceutical companies planning to introduce similar products in a growing market
We know that in recent studies aspirin hasnt proven beneficial for primary prevention in people who dont have established cardiovascular disease